Zeo ScientifiX partners with Physicians Group for Phase 2 clinical trials

Zeo ScientifiX, Inc.

Physicians Group operates 75 clinics and 750+ clinicians, treating 1,500-2,000 patients monthly.
Collaboration targets Phase 2 trials of Zofin™ for several indications and other pipeline products.
Zeo completed Phase 1 for Zofin; aims for FDA approval for various diseases and chronic conditions.
Regenerative medicine market projected to reach ~$175B by 2032 with 22.8% CAGR per Precedence Research.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.